药物对比
Miglitol vs Tolbutamide
Miglitol作为α-葡萄糖苷酶抑制剂减缓肠道葡萄糖吸收，而Tolbutamide作为磺脲类药物增加胰岛素释放，用于2型糖尿病的管理。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes may compare Miglitol, an alpha-glucosidase inhibitor, and Tolbutamide, a sulfonylurea, when selecting between agents targeting postprandial versus fasting hyperglycemia.
结论
Miglitol and Tolbutamide are distinct oral antidiabetic agents with different mechanisms of action, and the preferred medication depends on the patient's specific needs and glycemic targets.
全部药物对比